Capital Region Retina (site 316) — Albany, New York

Capital Region Retina (site 316) is a clinical research site located in Albany, New York, United States 12206.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Capital Region Retina (site 316) has participated in 1 clinical trials.

Therapeutic areas: Macular Degeneration.

Sponsors: OPKO Health, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Region Retina (site 316)?

Capital Region Retina (site 316) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Region Retina (site 316) conducted?

Capital Region Retina (site 316) has 1 clinical trials on record. Their work covers Macular Degeneration.

Is Capital Region Retina (site 316) accredited by Crixeo Health?

Capital Region Retina (site 316) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Region Retina (site 316)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.